Therefore, when anti-PD-1 or anti-PD-L1 antibodies are allowed to react to a specified antigen, PD-1 is unable to bind to PD-L1, and an anti-tumour effect is exerted by disabling their immunotolerance [8]. The gene discussed is CD274; the disease is neoplasm.